Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Sutherland, Katherine A; Parry, Chris M; McCormick, Adele; Kapaata, Anne; Lyagoba, Fred; Kaleebu, Pontiano; Gilks, Charles F; Goodall, Ruth; Spyer, Moira; Kityo, Cissy; +3 more... Pillay, Deenan; Gupta, Ravindra K; DART Virology Group; (2015) Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PloS one, 10 (9). e0137834-. ISSN 1932-6203 DOI: https://doi.org/10.1371/journal.pone.0137834

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pone.0137834

Abstract

Share

Download

Filename: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monother.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar